Should I Buy — Cvs Stock

: After a challenging 2024, the company's 2025 revenue hit a record $402.1 billion , with adjusted EPS rising over 24% to $6.75.

CVS Health Corporation (CVS) currently holds a consensus from Wall Street analysts, with 20 out of 24 experts recommending it as a top pick as of late April 2026. Trading near $78.38 , the stock is widely considered an attractive value play due to its low valuation relative to its $400+ billion annual revenue and robust cash flow. Key Investment Highlights should i buy cvs stock

The company has increased its dividend by 33% since 2022 and currently pays annually. : After a challenging 2024, the company's 2025

: The stock trades at roughly 11x forward earnings , significantly below its historical average of 12-15x. Morningstar estimates a fair value of $97.00 . Key Investment Highlights The company has increased its

: CVS offers a 3.4% dividend yield , which is more than double the S&P 500 average.

AI responses may include mistakes. For financial advice, consult a professional. Learn more Is CVS Health the Ultimate Value Stock to Buy Right Now?

Management projects 2026 adjusted EPS between .